Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 per share | 48.6K | $2.05M | $42.12 | Jun 18, 2024 | Direct |
Corbus Pharmaceuticals Holdings, Inc. | Chief Financial Officer | Common Stock | 48.6K | $1.46M | $30.00 | Apr 10, 2024 | Direct |
Corbus Pharmaceuticals Holdings, Inc. | Chief Financial Officer | Options to purchase common stock | 0 | $0 | $4.97 | Jun 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jun 14, 2024 | 12 | -$630K | 4 | Jun 18, 2024 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Apr 10, 2024 | 2 | $53.6K | 4 | Apr 11, 2024 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Feb 12, 2024 | 2 | $0 | 4 | Feb 14, 2024 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Feb 13, 2023 | 1 | $0 | 4 | Feb 15, 2023 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Aug 10, 2022 | 1 | $5.2K | 4 | Aug 10, 2022 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 16, 2022 | 1 | $3.6K | 4 | May 16, 2022 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Mar 10, 2022 | 1 | $5.55K | 4 | Mar 10, 2022 | Chief Financial Officer |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Financial Officer |